Glaxosmithkline Share News (GSK)
GSK Share
GSK Share
GSK Share
GSK Share
GSK
GSK Share
GSK Level 2
GSK Live
GSK Broker
GSK Directors
GSK Financial
GSK
GSK Short
GSK
Last checked at -
* European stock futures up 0.2%* Welcome to the home for real-time coverage of markets brought to you by Reuters reporters. You can share your thoughts with us at markets.research@thomsonreuters.comON THE RADAR: IBERDROLA UNIT MERGER, AKZO NOBEL, ...
Read moreFRANKFURT, Oct 21 (Reuters) - GlaxoSmithKline said it would move its experimental vaccine against the respiratory syncytial virus (RSV), a cause of pneumonia in toddlers and the elderly, into the final stage of testing, encouraged by mid-stage tr...
Read more
Glaxo's ViiV Gets Vocabria Boost From European Regulator
Read more* Favourable immune response in mice, monkeys for vaccine* Human clinical trial expected to begin in fourth quarterBy Matthias BlamontPARIS, Oct 15 (Reuters) - Clinical trials of an experimental vaccine against COVID-19 which is being developed by F...
Read moreUK BROKER RATINGS SUMMARY: Berenberg Upgrades TalkTalk To Hold
Read moreUK BROKER RATINGS SUMMARY: National Express Made "ESG Top Pick"
Read more* Thousands of staff seen at risk of undetected infection - union* Some banks ask staff to store phones away to prevent data leaks* Govt advises NHS app should be paused if phone not on person (Adds TSB comment)By Iain Withers and Sinead CruiseLO...
Read more* Thousands of staff seen at risk of undetected infection - union* Some banks ask staff to store phones away to prevent data leaks* Govt advises NHS app should be paused if phone not on person (Adds Department of Health comment)By Iain Withers an...
Read more
(Sharecast News) - US drug giant Eli Lilly's monoclonal antibody treatment is effective in reducing levels of the novel coronavirus in patients and appears to be able to keep them from having to go go the emergency room or hospital, the company said.
Read more(Adds J&J, details, background)By Francesco GuarascioBRUSSELS, Oct 8 (Reuters) - The European Union has sealed a deal with Johnson & Johnson to supply up to 400 million doses of its potential COVID-19 vaccine, as the bloc builds up stocks amid a g...
Read moreTOP NEWS: Glaxo And Vir's Study Of VIR-7831 In Covid Moves To Phase 3
Read more* Interim results expected before year-end* Full efficacy results possible as early as January* Regeneron, Eli Lilly are ahead in antibody race (Adds background on rivals, drug class)By Ludwig BurgerOct 6 (Reuters) - GlaxoSmithKline and partner Vir ...
Read moreOct 6 (Reuters) - GlaxoSmithKline and partner Vir Biotechnology will expand their trial of an experimental antibody to treat COVID-19 after initial use by a group of volunteers did not raise any safety concerns.The two partners in August started t...
Read moreLONDON, Oct 5 (Reuters) - U.S. chip giant Nvidia said on Monday it is building Britain's most powerful supercomputer, which will use artificial intelligence to help researchers solve pressing medical challenges, including those related to COVID-1...
Read moreUK BROKER RATINGS SUMMARY: Jefferies Cuts Man Group And Jupiter Fund
Read more
Last checked at